Who owns Loxonin?
Loxonin is owned by Daiichi Sankyo Healthcare (Japan).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Daiichi Sankyo Healthcare: History (沿革), Daiichi Sankyo Healthcare Co., Ltd. Last checked .
Key facts
- Current owner
- Daiichi Sankyo Healthcare Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Tokyo
- Origin
- 🇯🇵 Japan
- Founded
- 1986
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Last verified
- · 1 sources
About Loxonin
Painkiller brand that began as the prescription Loxonin tablet in 1986, developed as a prodrug that is gentle on the stomach and acts after absorption. In 2011 Loxonin S became the first first-class OTC switch medicine after the Japanese law change. Daiichi Sankyo Healthcare also sells Loxonin S topical products from 2016.
Ownership timeline of Loxonin
- Current owner Daiichi Sankyo Healthcare [1] reported
Where Loxonin sits in Daiichi Sankyo Healthcare
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Daiichi Sankyo Healthcare ownership tree →
See the full Daiichi Sankyo Healthcare brand portfolio (8) →
Other brands owned by Daiichi Sankyo Healthcare
Daiichi Sankyo Healthcare controls 8 brands on Brandtree, 5 of them in consumer health.
Also in consumer health
- Daiichi Sankyo Stomach Medicine (1957)
- Gaster 10 (1997)
- Lulu (1951)
- Makiron (1971)
Founded in the 1980s
- Clean Dental (1985)
Other brands in pain relief, and who owns them
The 34 brands in pain relief on Brandtree belong to 19 owners. The largest is Haleon, with 3.
| Brand | Owner | Owner based in |
|---|---|---|
| Advil | Haleon | 🇬🇧 United Kingdom |
| Air Salonpas | Hisamitsu Pharmaceutical | 🇯🇵 Japan |
| Motrin | Kenvue | 🇺🇸 United States |
| Dafalgan | Taisho Pharmaceutical | 🇯🇵 Japan |
| Mentho Plus | Emami | 🇮🇳 India |
| Bufferin (United States) | Genomma Lab | 🇲🇽 Mexico |
| Doril | Hypera | 🇧🇷 Brazil |
| Daleron | Krka | 🇸🇮 Slovenia |
About the owner: Daiichi Sankyo Healthcare
Daiichi Sankyo Healthcare is a privately held company headquartered in Tokyo, Japan, founded in 2005. Brandtree records 8 brands under its control.
Japanese self-care and over-the-counter health company, incorporated on 16 December 2005 and trading from 2006, when the healthcare businesses of Sankyo and Daiichi Seiyaku were combined. Zepharma joined in 2007. Its head office is in Nihonbashi, Tokyo, and it reported sales of 90.7 billion yen for the year to March 2026. Its site is in Japanese only; the brands below come from its launch history and brand list.
Daiichi Sankyo Healthcare: full profile, brands and acquisition history →
🇯🇵 Loxonin and other Japanese brands
Brandtree records a controlling owner for 437 brands that began in Japan. 21 of them (5%) are now controlled by a company headquartered in another country; Loxonin is not one of them.
- Air Salonpas — Hisamitsu Pharmaceutical 🇯🇵
- Ammeltz — Kobayashi Pharmaceutical 🇯🇵
- Biofermin — Taisho Pharmaceutical 🇯🇵
- Jelly Monster — Okamoto Industries 🇯🇵
- "K" Line — K Line 🇯🇵
- ABEMA — CyberAgent 🇯🇵
Frequently asked questions
Who is the parent company of Loxonin?
The parent company of Loxonin is Daiichi Sankyo Healthcare, a privately held company headquartered in Japan.
Is Loxonin Japanese?
Yes. Loxonin originated in Japan in 1986 and its owner, Daiichi Sankyo Healthcare, is also headquartered in Japan.
Is Loxonin still owned by Daiichi Sankyo Healthcare?
Yes. As of 4 October 2026, Loxonin is still owned by Daiichi Sankyo Healthcare. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Daiichi Sankyo Healthcare: History (沿革) — Daiichi Sankyo Healthcare Co., Ltd., Official document; retrieved 4 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.